Loading…

A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome

Hyperparathyroidism–jaw tumour syndrome (HPT-JT) is a rare variant of familial hyperparathyroidism, characterized by primary hyperparathyroidism (PHPT) due to one or multiple parathyroid adenomas, and benign tumours of the mandible and maxilla. It has an autosomal dominant pattern of inheritance, an...

Full description

Saved in:
Bibliographic Details
Published in:Endocrine pathology 2016-06, Vol.27 (2), p.142-146
Main Authors: Bellido, Virginia, Larrañaga, Ihintza, Guimón, Maite, Martinez-Conde, Rafael, Eguia, Asier, Perez de Nanclares, Gustavo, Castaño, Luis, Gaztambide, Sonia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c372t-b75565a6bee90331564e1001242b9cfa16cc85040fe9530edbbba91faa6d09c83
cites cdi_FETCH-LOGICAL-c372t-b75565a6bee90331564e1001242b9cfa16cc85040fe9530edbbba91faa6d09c83
container_end_page 146
container_issue 2
container_start_page 142
container_title Endocrine pathology
container_volume 27
creator Bellido, Virginia
Larrañaga, Ihintza
Guimón, Maite
Martinez-Conde, Rafael
Eguia, Asier
Perez de Nanclares, Gustavo
Castaño, Luis
Gaztambide, Sonia
description Hyperparathyroidism–jaw tumour syndrome (HPT-JT) is a rare variant of familial hyperparathyroidism, characterized by primary hyperparathyroidism (PHPT) due to one or multiple parathyroid adenomas, and benign tumours of the mandible and maxilla. It has an autosomal dominant pattern of inheritance, and is associated with mutations that deactivate the cell division cycle protein 73 homolog ( CDC73 ) gene, also known as hyperparathyroidism 2 ( HRPT2 ), located on the long arm of chromosome 1, that encodes for the tumour suppressor protein parafibromin. In the majority of cases, PHPT is the presenting symptom, but up to 30 % of HPT-JT cases initially present with an ossifying fibroma of the maxillofacial bones. HPT-JT may result in severe hypercalcemia-related complications and an elevated risk of parathyroid carcinoma. For this reason, early identification of the disease is important. We present the case of a 23-year-old woman who was found to have jaw tumours and was later diagnosed with PHPT. Genetic analysis revealed a novel mutation in exon 1 of CDC73 . This report contributes to the understanding of the genetics of this rare syndrome. It also highlights the fact that HPT-JT should be considered and CDC73 mutation analysis should be performed in cases of early-onset PHPT associated with ossifying fibromas of the jaw.
doi_str_mv 10.1007/s12022-016-9427-6
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1785214024</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4035724341</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-b75565a6bee90331564e1001242b9cfa16cc85040fe9530edbbba91faa6d09c83</originalsourceid><addsrcrecordid>eNp1kEtOwzAQhi0EoqVwADbIEhs2gbFjO_GyqoCCykOirC0ncWiqPIqdUHXHHbghJ8FVC0JIrDySv_ln5kPomMA5AYguHKFAaQBEBJLRKBA7qE84lwGAjHZ9DUwEoYxEDx04NwcgIQDdRz0qpOQe6qPJEN83b6bEd12r26KpcVFjjR99beoWL4t2hserhbELbXU7W9mmyApXfb5_3OolnnZV01n8tKoz21TmEO3lunTmaPsO0PPV5XQ0DiYP1zej4SRIw4i2QRJxLrgWiTESwpBwwYy_h1BGE5nmmog0jTkwyI3kIZgsSRItSa61yECmcThAZ5vchW1eO-NaVRUuNWWpa9N0TpEo5pQwoMyjp3_Qud-49tutKcZIHPHQU2RDpbZxzppcLWxRabtSBNRatdqoVl61WqtWwvecbJO7pDLZT8e3Ww_QDeD8V_1i7K_R_6Z-ASTmiRk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1784418753</pqid></control><display><type>article</type><title>A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome</title><source>Springer Link</source><creator>Bellido, Virginia ; Larrañaga, Ihintza ; Guimón, Maite ; Martinez-Conde, Rafael ; Eguia, Asier ; Perez de Nanclares, Gustavo ; Castaño, Luis ; Gaztambide, Sonia</creator><creatorcontrib>Bellido, Virginia ; Larrañaga, Ihintza ; Guimón, Maite ; Martinez-Conde, Rafael ; Eguia, Asier ; Perez de Nanclares, Gustavo ; Castaño, Luis ; Gaztambide, Sonia</creatorcontrib><description>Hyperparathyroidism–jaw tumour syndrome (HPT-JT) is a rare variant of familial hyperparathyroidism, characterized by primary hyperparathyroidism (PHPT) due to one or multiple parathyroid adenomas, and benign tumours of the mandible and maxilla. It has an autosomal dominant pattern of inheritance, and is associated with mutations that deactivate the cell division cycle protein 73 homolog ( CDC73 ) gene, also known as hyperparathyroidism 2 ( HRPT2 ), located on the long arm of chromosome 1, that encodes for the tumour suppressor protein parafibromin. In the majority of cases, PHPT is the presenting symptom, but up to 30 % of HPT-JT cases initially present with an ossifying fibroma of the maxillofacial bones. HPT-JT may result in severe hypercalcemia-related complications and an elevated risk of parathyroid carcinoma. For this reason, early identification of the disease is important. We present the case of a 23-year-old woman who was found to have jaw tumours and was later diagnosed with PHPT. Genetic analysis revealed a novel mutation in exon 1 of CDC73 . This report contributes to the understanding of the genetics of this rare syndrome. It also highlights the fact that HPT-JT should be considered and CDC73 mutation analysis should be performed in cases of early-onset PHPT associated with ossifying fibromas of the jaw.</description><identifier>ISSN: 1046-3976</identifier><identifier>EISSN: 1559-0097</identifier><identifier>DOI: 10.1007/s12022-016-9427-6</identifier><identifier>PMID: 26995009</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adenoma - genetics ; DNA Mutational Analysis ; Endocrinology ; Female ; Fibroma - genetics ; Humans ; Hyperparathyroidism - genetics ; Jaw Neoplasms - genetics ; Medicine ; Medicine &amp; Public Health ; Mutation ; Oncology ; Pathology ; Polymerase Chain Reaction ; Tumor Suppressor Proteins - genetics ; Young Adult</subject><ispartof>Endocrine pathology, 2016-06, Vol.27 (2), p.142-146</ispartof><rights>Springer Science+Business Media New York 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-b75565a6bee90331564e1001242b9cfa16cc85040fe9530edbbba91faa6d09c83</citedby><cites>FETCH-LOGICAL-c372t-b75565a6bee90331564e1001242b9cfa16cc85040fe9530edbbba91faa6d09c83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26995009$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bellido, Virginia</creatorcontrib><creatorcontrib>Larrañaga, Ihintza</creatorcontrib><creatorcontrib>Guimón, Maite</creatorcontrib><creatorcontrib>Martinez-Conde, Rafael</creatorcontrib><creatorcontrib>Eguia, Asier</creatorcontrib><creatorcontrib>Perez de Nanclares, Gustavo</creatorcontrib><creatorcontrib>Castaño, Luis</creatorcontrib><creatorcontrib>Gaztambide, Sonia</creatorcontrib><title>A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome</title><title>Endocrine pathology</title><addtitle>Endocr Pathol</addtitle><addtitle>Endocr Pathol</addtitle><description>Hyperparathyroidism–jaw tumour syndrome (HPT-JT) is a rare variant of familial hyperparathyroidism, characterized by primary hyperparathyroidism (PHPT) due to one or multiple parathyroid adenomas, and benign tumours of the mandible and maxilla. It has an autosomal dominant pattern of inheritance, and is associated with mutations that deactivate the cell division cycle protein 73 homolog ( CDC73 ) gene, also known as hyperparathyroidism 2 ( HRPT2 ), located on the long arm of chromosome 1, that encodes for the tumour suppressor protein parafibromin. In the majority of cases, PHPT is the presenting symptom, but up to 30 % of HPT-JT cases initially present with an ossifying fibroma of the maxillofacial bones. HPT-JT may result in severe hypercalcemia-related complications and an elevated risk of parathyroid carcinoma. For this reason, early identification of the disease is important. We present the case of a 23-year-old woman who was found to have jaw tumours and was later diagnosed with PHPT. Genetic analysis revealed a novel mutation in exon 1 of CDC73 . This report contributes to the understanding of the genetics of this rare syndrome. It also highlights the fact that HPT-JT should be considered and CDC73 mutation analysis should be performed in cases of early-onset PHPT associated with ossifying fibromas of the jaw.</description><subject>Adenoma - genetics</subject><subject>DNA Mutational Analysis</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Fibroma - genetics</subject><subject>Humans</subject><subject>Hyperparathyroidism - genetics</subject><subject>Jaw Neoplasms - genetics</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mutation</subject><subject>Oncology</subject><subject>Pathology</subject><subject>Polymerase Chain Reaction</subject><subject>Tumor Suppressor Proteins - genetics</subject><subject>Young Adult</subject><issn>1046-3976</issn><issn>1559-0097</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kEtOwzAQhi0EoqVwADbIEhs2gbFjO_GyqoCCykOirC0ncWiqPIqdUHXHHbghJ8FVC0JIrDySv_ln5kPomMA5AYguHKFAaQBEBJLRKBA7qE84lwGAjHZ9DUwEoYxEDx04NwcgIQDdRz0qpOQe6qPJEN83b6bEd12r26KpcVFjjR99beoWL4t2hserhbELbXU7W9mmyApXfb5_3OolnnZV01n8tKoz21TmEO3lunTmaPsO0PPV5XQ0DiYP1zej4SRIw4i2QRJxLrgWiTESwpBwwYy_h1BGE5nmmog0jTkwyI3kIZgsSRItSa61yECmcThAZ5vchW1eO-NaVRUuNWWpa9N0TpEo5pQwoMyjp3_Qud-49tutKcZIHPHQU2RDpbZxzppcLWxRabtSBNRatdqoVl61WqtWwvecbJO7pDLZT8e3Ww_QDeD8V_1i7K_R_6Z-ASTmiRk</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>Bellido, Virginia</creator><creator>Larrañaga, Ihintza</creator><creator>Guimón, Maite</creator><creator>Martinez-Conde, Rafael</creator><creator>Eguia, Asier</creator><creator>Perez de Nanclares, Gustavo</creator><creator>Castaño, Luis</creator><creator>Gaztambide, Sonia</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20160601</creationdate><title>A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome</title><author>Bellido, Virginia ; Larrañaga, Ihintza ; Guimón, Maite ; Martinez-Conde, Rafael ; Eguia, Asier ; Perez de Nanclares, Gustavo ; Castaño, Luis ; Gaztambide, Sonia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-b75565a6bee90331564e1001242b9cfa16cc85040fe9530edbbba91faa6d09c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adenoma - genetics</topic><topic>DNA Mutational Analysis</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Fibroma - genetics</topic><topic>Humans</topic><topic>Hyperparathyroidism - genetics</topic><topic>Jaw Neoplasms - genetics</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mutation</topic><topic>Oncology</topic><topic>Pathology</topic><topic>Polymerase Chain Reaction</topic><topic>Tumor Suppressor Proteins - genetics</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bellido, Virginia</creatorcontrib><creatorcontrib>Larrañaga, Ihintza</creatorcontrib><creatorcontrib>Guimón, Maite</creatorcontrib><creatorcontrib>Martinez-Conde, Rafael</creatorcontrib><creatorcontrib>Eguia, Asier</creatorcontrib><creatorcontrib>Perez de Nanclares, Gustavo</creatorcontrib><creatorcontrib>Castaño, Luis</creatorcontrib><creatorcontrib>Gaztambide, Sonia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bellido, Virginia</au><au>Larrañaga, Ihintza</au><au>Guimón, Maite</au><au>Martinez-Conde, Rafael</au><au>Eguia, Asier</au><au>Perez de Nanclares, Gustavo</au><au>Castaño, Luis</au><au>Gaztambide, Sonia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome</atitle><jtitle>Endocrine pathology</jtitle><stitle>Endocr Pathol</stitle><addtitle>Endocr Pathol</addtitle><date>2016-06-01</date><risdate>2016</risdate><volume>27</volume><issue>2</issue><spage>142</spage><epage>146</epage><pages>142-146</pages><issn>1046-3976</issn><eissn>1559-0097</eissn><abstract>Hyperparathyroidism–jaw tumour syndrome (HPT-JT) is a rare variant of familial hyperparathyroidism, characterized by primary hyperparathyroidism (PHPT) due to one or multiple parathyroid adenomas, and benign tumours of the mandible and maxilla. It has an autosomal dominant pattern of inheritance, and is associated with mutations that deactivate the cell division cycle protein 73 homolog ( CDC73 ) gene, also known as hyperparathyroidism 2 ( HRPT2 ), located on the long arm of chromosome 1, that encodes for the tumour suppressor protein parafibromin. In the majority of cases, PHPT is the presenting symptom, but up to 30 % of HPT-JT cases initially present with an ossifying fibroma of the maxillofacial bones. HPT-JT may result in severe hypercalcemia-related complications and an elevated risk of parathyroid carcinoma. For this reason, early identification of the disease is important. We present the case of a 23-year-old woman who was found to have jaw tumours and was later diagnosed with PHPT. Genetic analysis revealed a novel mutation in exon 1 of CDC73 . This report contributes to the understanding of the genetics of this rare syndrome. It also highlights the fact that HPT-JT should be considered and CDC73 mutation analysis should be performed in cases of early-onset PHPT associated with ossifying fibromas of the jaw.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>26995009</pmid><doi>10.1007/s12022-016-9427-6</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1046-3976
ispartof Endocrine pathology, 2016-06, Vol.27 (2), p.142-146
issn 1046-3976
1559-0097
language eng
recordid cdi_proquest_miscellaneous_1785214024
source Springer Link
subjects Adenoma - genetics
DNA Mutational Analysis
Endocrinology
Female
Fibroma - genetics
Humans
Hyperparathyroidism - genetics
Jaw Neoplasms - genetics
Medicine
Medicine & Public Health
Mutation
Oncology
Pathology
Polymerase Chain Reaction
Tumor Suppressor Proteins - genetics
Young Adult
title A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T08%3A49%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Novel%20Mutation%20in%20a%20Patient%20with%20Hyperparathyroidism%E2%80%93Jaw%20Tumour%20Syndrome&rft.jtitle=Endocrine%20pathology&rft.au=Bellido,%20Virginia&rft.date=2016-06-01&rft.volume=27&rft.issue=2&rft.spage=142&rft.epage=146&rft.pages=142-146&rft.issn=1046-3976&rft.eissn=1559-0097&rft_id=info:doi/10.1007/s12022-016-9427-6&rft_dat=%3Cproquest_cross%3E4035724341%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-b75565a6bee90331564e1001242b9cfa16cc85040fe9530edbbba91faa6d09c83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1784418753&rft_id=info:pmid/26995009&rfr_iscdi=true